National Security > COVID-19 Resource Center
29 Mar '20

Whatever your business—whether you are an investor looking at new investments, managing existing positions or planning exits, or a corporate concerned with protecting and enhancing your business—the current public health crisis has brought a host of additional risks and challenges to the U.A.E.

Read more to access the latest updates on the Government and Industry Actions across the U.A.E.

Read More

28 Mar '20

Whatever your business—whether you are an investor looking at new investments, managing existing positions or planning exits, or a corporate concerned with protecting and enhancing your business—the current public health crisis has brought a host of additional risks and challenges to the U.A.E.

Read more to access the latest updates on the Government and Industry Actions across the U.A.E.

Read More

27 Mar '20

Whatever your business—whether you are an investor looking at new investments, managing existing positions or planning exits, or a corporate concerned with protecting and enhancing your business—the current public health crisis has brought a host of additional risks and challenges to the U.A.E.

Read more to access the latest updates on the Government and Industry Actions across the U.A.E.

 

Read More

27 Mar '20

President Trump Signs $2 Trillion Phase 3 Deal 

Today, President Trump signed a $2 trillion Phase 3 economic stimulus package in response to the Coronavirus pandemic, the Coronavirus Aid, Relief and Economic Security (CARES) Act, which passed the House of Representatives by voice vote today, despite efforts from Rep. Thomas Massie (R-KY) to stall progress on the bill until a recorded vote could be taken.

Read More

27 Mar '20

Enforcers across the federal government are focusing on fraud risks related to the Coronavirus (COVID-19) pandemic and resulting market turmoil. This post summarizes recent enforcement actions and public statements by regulatory and criminal authorities arising out of the COVID-19 pandemic. Public companies, as well as investment advisers, broker-dealers and other regulated entities, should be mindful of these rapidly emerging trends to protect themselves from fraudulent activity by others and to minimize the risk of misconduct within their own organizations.

Read more

Read More

27 Mar '20

In the economic turbulence caused by COVID-19 and the Russia-Saudi Arabia oil price dispute, many energy companies’ debt is now trading well below par value.  For affected companies, sinking debt valuations present an opportunity to manage their liabilities by selectively repurchasing their debt and de-levering at a significant discount.  By being aware of the corporate, securities law and tax ramifications of debt buybacks, companies that are well-situated to capitalize on this window can maximize its benefit and avoid potential pitfalls.

Read more.

Read More

27 Mar '20

The European Commission (EC) on March 25, 2020 issued new guidance on foreign investment screening in response to the COVID-19 emergency1 (the “Guidance”). The Guidance, which addresses the now 27 EU Member States and relates in particular (but which is “by no means limited”) to health care-related industries, sets out a threefold action plan to tackle COVID-19-related foreign investment risk.

Read more.

Read More

27 Mar '20

While the United States now leads the world with the number of reported cases of COVID-19, the Coronavirus Aid, Relief, and Economic Security (CARES) Act (or “the Act”) takes major, though perhaps still incomplete, steps toward supporting the nation’s health care system as it responds to this unprecedented health and financial crisis. In sum, and as described further below, the Act includes provisions to expand access to diagnostic testing and telehealth; bolster the stockpile of personal protective equipment and other needed supplies; mitigate drug and device shortages; and provide financial support and flexibilities for providers to respond to the outbreak. The package contains additional appropriations for the Department of Health and Human Services (HHS), including $100 billion to reimburse hospitals and other providers for expenditures and lost revenues related to COVID-19, among billions of dollars in other supplemental funding for HHS agencies.

Read More